AM Pharma Competitors and Similar CompaniesClear all
AM Pharma's competitors and similar companies include PlasmaGen Biosciences, Immatics, Alexion Pharmaceuticals and Macopharma.
 PlasmaGen Biosciences PlasmaGen BioSciences is a bio-pharmaceutical organization specializing in plasma protein therapy. |  Immatics Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer. |  Alexion Pharmaceuticals Alexion (also known as Alexion, AstraZeneca Rare Disease) is a biopharmaceutical company engaged in therapies for rare diseases. | |||
Founding Date | Founding Date 2001 | Founding Date 2010 | Founding Date N/A | Founding Date 1992 | Founding Date 1977 |
Type | Type Private | Type Private | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Utrecht, NL HQ Utrecht, NL | Locations Bengaluru, IN HQ Bengaluru, IN | Locations Tübingen, DE HQ Frankfurt Am Main, DE München, DE Houston, US | Locations Boston, US HQ Frenchs Forest, AU Wien, AT Elsene, BE São Paulo, BR Vaughan, CA Shanghai, CN see more | Locations Tourcoing, FR HQ Mouvaux, FR |
Employees | Employees 28 | Employees 4032% increase | Employees 29723% increase | Employees 10,6006% increase | Employees 901 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 1.1 b | Valuation ($) 40.3 b | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) €48.3m (FY, 2025) | Revenue (est.) $6.1b (FY, 2020) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods $553.5m (FY, 2020) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit €53m (FY, 2025) | Gross profit $5.5b (FY, 2020) | Gross profit N/A |
Net income | Net income N/A | Net income N/A | Net income (€196.4m) (FY, 2025) | Net income $603.4m (FY, 2020) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round $ 24m (about 6 years ago) | Latest funding round $ 25m (almost 9 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 210.3m | Total funding raised $ 25m | Total funding raised $ 267.3m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
PlasmaGen Biosciences
HQ
Bengaluru, IN
Employees
403↑ 2% increase
PlasmaGen BioSciences is a bio-pharmaceutical organization specializing in plasma protein therapy.
View companyImmatics
HQ
Tübingen, DE
Employees
297↑ 23% increase
Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer.
View companyAlexion Pharmaceuticals
HQ
Boston, US
Employees
10,600↑ 6% increase
Alexion (also known as Alexion, AstraZeneca Rare Disease) is a biopharmaceutical company engaged in therapies for rare diseases.
View company
Macopharma
HQ
Tourcoing, FR
Employees
901
Macopharma is a provider of blood transfusion and bio-sourced therapies.
View company